Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares with no par value
-
Shares outstanding
-
18,772,286
-
Total 13F shares
-
124,340
-
Share change
-
+110,416
-
Total reported value
-
$221,398
-
Price per share
-
$1.78
-
Number of holders
-
6
-
Value change
-
+$196,613
-
Number of buys
-
5
Institutional Holders of Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) as of Q2 2025
As of 30 Jun 2025,
Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,340 shares.
The largest 6 holders included
HRT FINANCIAL LP, Virtu Financial LLC, Marex Group plc, UBS Group AG, BARCLAYS PLC, and Tower Research Capital LLC (TRC).
This page lists
6
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.